Concepedia

Author

Fu Xiong

Huazhong University of Science and TechnologyORCID

Also Known As

F Xiong, F.L. Xiong, Feiyang Xiong, Fu Xiong, Guo‐Yong Wu

34

Publications

184

Citations

9

H-Index

11

Concepts

All Affiliations

Huazhong University of Science and TechnologyUnion HospitalState Key Laboratory of Information Engineering in Surveying Mapping and Remote Sensing
FX

About

Fu Xiong is an author at Huazhong University of Science and Technology specializing in hepatology, radiation oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

25

2

Hepatology

2

2

25

3

Pathology

1

1

12

4

Surgical Oncology

1

1

13

5

Vascular Surgery

1

1

13

Fu Xiong

×

7

Publications

112

Citations

7

H-Index

YearCitations

Effect of Transcatheter Intraarterial Therapies on the Distribution of Doxorubicin in Liver Cancer in a Rabbit Model

Bin Liang, Fu Xiong, Han‐Ping Wu,

PLoS ONE

2013

33

Correlation Between Chest CT Findings and Clinical Features of 211 COVID-19 Suspected Patients in Wuhan, China

Songlin Song, Feihong Wu, Yiming Liu,

Open Forum Infectious Diseases

2020

18

Research progress of triptolide-loaded nanoparticles delivery systems

Fu Xiong, H.B. Chen, Xinyu Chang,

2005

16

Effect of Transcatheter Intra-Arterial Therapies on Tumor Interstitial Fluid Pressure and Its Relation to Drug Penetration in a Rabbit Liver Tumor Model

Bin Liang, Lin Li, Yiming Liu,

Journal of Vascular and Interventional Radiology

2015

13

Efficacy of apatinib in patients with sorafenib–transarterial chemoembolization refractory hepatocellular carcinoma: a retrospective study

Yanyan Cao, Tao Ouyang, Fu Xiong,

Hepatology International

2021

12

Endovascular management of transplant renal artery stenosis: A single‐center retrospective study

Yanqiao Ren, Fu Xiong, Xuefeng Kan,

Catheterization and Cardiovascular Interventions

2019

10

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma

Yanqiao Ren, Yusheng Guo, Lei Chen,

Cancer Control

2022

10

Page 1